PARADIGM BIO. ORDINARY (PAR) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXListing of Options - Top 20 Holders and Distribution Reports
other announcement
Google NewsParadigm Biopharma (ASX:PAR) Shares Jump on Monday – Here’s Why - Kalkine
Paradigm Biopharma (ASX:PAR) Shares Jump on Monday – Here’s Why Kalkine
KalkineWhy Paradigm’s Massive New Share Issue Is Drawing Attention
Highlights Paradigm Biopharmaceuticals applied for quotation of more than forty-three million new ordinary shares on the ASX. The expanded share base is expected to increase trading liquidity and market participation. The move supports the company’s ongoing capital management and pharmaceutical development activities. Paradigm Biopharmaceuticals has applied to quote more than forty-three million new shares on the ASX. The move expands tradable securities, enhances liquidity Paradigm Bio...
Paradigm Biopharmaceuticals (ASX:PAR) Strengthens Balance Sheet Ahead of Key Clinical Trial Milestones - Kalkine
Paradigm Biopharmaceuticals (ASX:PAR) Strengthens Balance Sheet Ahead of Key Clinical Trial Milestones Kalkine
Small CapsDSMB 20% Review Supports Phase 3, Moldova Activated
other announcement
OARSI Theatre Presentation Showcases iPPS Biomarker Data
other announcement
Why Is (ASX:PAR) Highlighted in ASX Healthcare Sector?
Highlights Biotech company advances capital raising through placement and SPP. Healthcare sector activity reflects funding initiatives across ASX. Market participation highlights evolving financial strategies. Biotech company Paradigm Biopharmaceuticals advances capital raising efforts, highlighting funding strategies and ongoing activity within the ASX healthcare sector. The Australian biotechnology and healthcare sector continues to play a significant role within the broader equity la...
March 2026 Quarterly Activities Report & Appendix 4C
other announcement
Upsized $14M Placement Extends Runway Post IA
capital_raise announcement
When Will Paradigm Biopharmaceuticals Limited (ASX:PAR) Turn A Profit? - simplywall.st
When Will Paradigm Biopharmaceuticals Limited (ASX:PAR) Turn A Profit? simplywall.st
Paradigm Announces OA Research Collaboration in UK
other announcement
Drawdown of Tranche 3 under the Convertible Note Facility
other announcement
Update on PAROA Exercise and Unmarketable Parcel Facility
other announcement
Published Canine Study Strengthens iPPS Phase 3 Rationale
other announcement
December 2025 Quarterly Activities Report & Appendix 4C
other announcement
iPPS Phase 2 Biomarker Results Published in Leading Journal
other announcement